0000899243-21-046845.txt : 20211203 0000899243-21-046845.hdr.sgml : 20211203 20211203184326 ACCESSION NUMBER: 0000899243-21-046845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211203 FILED AS OF DATE: 20211203 DATE AS OF CHANGE: 20211203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobs Bruce N. CENTRAL INDEX KEY: 0001821074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 211471497 MAIL ADDRESS: STREET 1: C/O KYMERA THERAPEUTICS, INC. STREET 2: 200 ARSENAL YARDS, SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-03 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001821074 Jacobs Bruce N. C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 0 1 0 0 Chief Financial Officer Common Stock 2021-12-03 4 M 0 10000 2.08 A 27514 D Common Stock 2021-12-03 4 S 0 7713 53.311 D 19801 D Common Stock 2021-12-03 4 S 0 1987 54.3177 D 17814 D Common Stock 2021-12-03 4 S 0 300 55.0667 D 17514 D Stock Option (Right to Buy) 2.08 2021-12-03 4 M 0 10000 0.00 D 2029-08-28 Common Stock 10000 189899 D This number includes 258 shares acquired under the Registrant's employee stock purchase plan on November 30, 2021. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.91 to $53.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.92 to $54.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.96 to $55.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. /s/ Bruce N. Jacobs 2021-12-03